Methallenestril: Difference between revisions
Rabin Bista (talk | contribs) Created page with "{{chembox new | UNII_Ref = {{fdacite|correct|FDA}} | UNII = XL025389JS | verifiedrevid = 437205113 |ImageFile=Methalenetril wiki str.png |ImageSize=200px |IUPACName=3-(6-Met..." |
m Protected "Methallenestril": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
(No difference)
|
Latest revision as of 16:41, 20 August 2015
WikiDoc Resources for Methallenestril |
Articles |
---|
Most recent articles on Methallenestril Most cited articles on Methallenestril |
Media |
Powerpoint slides on Methallenestril |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Methallenestril at Clinical Trials.gov Trial results on Methallenestril Clinical Trials on Methallenestril at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Methallenestril NICE Guidance on Methallenestril
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Methallenestril Discussion groups on Methallenestril Patient Handouts on Methallenestril Directions to Hospitals Treating Methallenestril Risk calculators and risk factors for Methallenestril
|
Healthcare Provider Resources |
Causes & Risk Factors for Methallenestril |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Methallenestril is an estrogen.[1] It is a seco-analogue of bisdehydrodoisynolic acid. Vallestril was a brand of methallenestril issued by G. D. Searle & Company in the 1950s.
References
- ↑ Herbai G, Ljunghall S (1983). "Normalization of hypercalcaemia of primary hyperparathyroidism by treatment with methallenestril, a synthetic oestrogen with low oestrogenicity". Urol. Int. 38 (6): 371–3. doi:10.1159/000280925. PMID 6659184.